Dexcom faces proposed class action suit over G7 CGM problems
Dexcom is sued in a proposed class action alleging defects in its G7 continuous glucose monitors, including alert failures and inaccurate readings.Summary
Dexcom is facing a proposed class action lawsuit filed in the U.S. District Court for the Central District of California, alleging defects in its G7 continuous glucose monitors (CGMs). The complaint, brought by parent Kelly Grisoli, claims the devices were “defective, prone to dangerous alert failures, and subject to recall” by the FDA. Grisoli alleges the G7 did not perform as advertised, providing inaccurate glucose readings and failing alerts, requiring frequent sensor replacements.
The lawsuit references previous warning letters and two Class I recalls issued this year regarding the G7, specifically concerning the lack of audible alarms and “sensor failed” alerts. Grisoli claims Dexcom threatened to stop replacing sensors due to frequent requests, and argues she wouldn’t have purchased the device had she known about the defects.
The plaintiff is seeking class action certification and unspecified damages, citing violations of California’s Consumer Legal Remedy Act, Unfair Competition Law, and False Advertising Law. Dexcom has not yet responded to requests for comment.
(Source：MedTech Dive)